Royalty Pharma plc
General ticker "RPRX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $11.5B
Royalty Pharma plc does not follow the US Stock Market performance with the rate: -25.0%.
Estimated limits based on current volatility of 1.5%: low 24.32$, high 25.04$
Factors to consider:
- Company pays dividends: last record date 2024-11-15, amount 0.21$ (Y3.33%)
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [18.16$, 29.80$]
- 2024-12-30 to 2025-12-30 estimated range: [16.45$, 27.55$]
Financial Metrics affecting the RPRX estimates:
- Positive: Non-GAAP EPS, $ of 4.39 > 2.29
- Positive: Operating cash flow per share per price, % of 23.95 > 12.76
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
- Positive: Operating profit margin, % of 63.37 > 19.51
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
Short-term RPRX quotes
Long-term RPRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $2,289.46MM | $2,237.22MM | $2,354.55MM |
| Operating Expenses | $858.75MM | $1,930.15MM | $862.40MM |
| Operating Income | $1,430.71MM | $307.06MM | $1,492.15MM |
| Non-Operating Income | $-189.51MM | $-77.00MM | $207.94MM |
| Interest Expense | $166.14MM | $187.96MM | $187.19MM |
| R&D Expense | $200.08MM | $177.11MM | $52.00MM |
| Income(Loss) | $1,241.20MM | $230.06MM | $1,700.09MM |
| Profit(Loss) | $1,241.20MM | $230.06MM | $1,700.09MM |
| Stockholders Equity | $10,248.55MM | $9,525.37MM | $10,084.29MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $17,515.87MM | $16,813.47MM | $16,381.85MM |
| Operating Cash Flow | $2,017.54MM | $2,143.98MM | $2,987.80MM |
| Capital expenditure | $0.52MM | $2,041.15MM | $0.00MM |
| Investing Cash Flow | $-1,870.28MM | $-1,029.42MM | $-2,072.79MM |
| Financing Cash Flow | $385.11MM | $-944.86MM | $-2,148.75MM |
| Earnings Per Share* | $1.15 | $0.10 | $3.41 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.